Our Journey Through Advanced Therapies to Reduce Post-Infarct Scarring
Stem Cell Rev Rep
.
2021 Oct;17(5):1928-1930.
doi: 10.1007/s12015-021-10190-2.
Epub 2021 May 22.
Authors
Santiago Roura
1
2
3
4
,
Marta Monguió-Tortajada
5
6
7
,
Cristina Prat-Vidal
5
6
7
8
,
Carolina Gálvez-Montón
5
6
7
,
Antoni Bayes-Genis
5
6
7
9
10
Affiliations
1
ICREC Research Program, Health Science Research Institute Germans Trias I Pujol, Can Ruti Campus, Badalona, Spain. sroura@igtp.cat.
2
Heart Institute (iCor), Germans Trias I PujolUniversityHospital, Badalona, Spain. sroura@igtp.cat.
3
CIBERCV, Instituto de Salud CarlosIII, Madrid, Spain. sroura@igtp.cat.
4
Faculty of Medicine, University of Vic-Central University of Catalonia, Vic, Spain. sroura@igtp.cat.
5
ICREC Research Program, Health Science Research Institute Germans Trias I Pujol, Can Ruti Campus, Badalona, Spain.
6
Heart Institute (iCor), Germans Trias I PujolUniversityHospital, Badalona, Spain.
7
CIBERCV, Instituto de Salud CarlosIII, Madrid, Spain.
8
Institut D'Investigació Biomèdica de Bellvitge - IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
9
Cardiology Service, Germans Trias I Pujol University Hospital, Badalona, Spain.
10
Department of Medicine, Universitat Autonoma de Barcelona, Barcelona, Spain.
PMID:
34021471
PMCID:
PMC8553692
DOI:
10.1007/s12015-021-10190-2
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Cicatrix* / therapy
Humans
Infarction*